{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T08:55:30Z","timestamp":1775638530166,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1245\/s10434-019-07751-8","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T16:05:16Z","timestamp":1566921916000},"page":"3856-3862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?"],"prefix":"10.1245","volume":"26","author":[{"given":"Anita","family":"Mamtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura H.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Stempel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary L.","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"7751_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.semdp.2009.12.009","volume":"27","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Ellis IO. Lobular breast carcinoma and its variants. Semin Diagn Pathol. 2010;27:49\u201361.","journal-title":"Semin Diagn Pathol"},{"key":"7751_CR2","doi-asserted-by":"crossref","unstructured":"Yeatman TJ, Cantor AB, Smith TJ, Smith SK, Reintgen DS, Miller MS, et al. Tumor biology of infiltrating lobular carcinoma: implications for management. Ann Surg. 1995;222:549\u201359; discussion 59\u201361.","DOI":"10.1097\/00000658-199510000-00012"},{"key":"7751_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.breast.2004.03.004","volume":"13","author":"JG Molland","year":"2004","unstructured":"Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ. Infiltrating lobular carcinoma: a comparison of diagnosis, management, and outcome with infiltrating duct carcinoma. Breast. 2004;13:389\u201396.","journal-title":"Breast"},{"key":"7751_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/00000658-200006000-00012","volume":"231","author":"MM Moore","year":"2000","unstructured":"Moore MM, Borossa G, Imbrie JZ, Fechner RE, Harvey JA, Slingluff CL, et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg. 2000;231:877\u201382.","journal-title":"Ann Surg"},{"key":"7751_CR5","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233\u201341.","journal-title":"N Engl J Med."},{"key":"7751_CR6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa020989","volume":"347","author":"U Veronesi","year":"2002","unstructured":"Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227\u201332.","journal-title":"N Engl J Med."},{"key":"7751_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.rpor.2011.06.005","volume":"16","author":"J Fodor","year":"2011","unstructured":"Fodor J, Major T, Toth J, Sulyok Z, Polgar C. Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-year results. Rep Pract Oncol Radiother. 2011;16:227\u201331.","journal-title":"Rep Pract Oncol Radiother."},{"key":"7751_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.soc.2017.07.005","volume":"27","author":"A Mamtani","year":"2018","unstructured":"Mamtani A, King TA. Lobular breast cancer: different disease, different algorithms? Surg Oncol Clin North Am. 2018;27:81\u201394.","journal-title":"Surg Oncol Clin North Am"},{"key":"7751_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijrobp.2013.11.012","volume":"88","author":"MS Moran","year":"2014","unstructured":"Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of Surgical Oncology\u2013American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88:553\u201364.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"7751_CR10","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1245\/s10434-016-5397-7","volume":"23","author":"LH Rosenberger","year":"2016","unstructured":"Rosenberger LH, Mamtani A, Fuzesi S, Stempel M, Eaton A, Morrow M, Gemignani ML. Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: initial experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol. 2016;23:3239\u201346.","journal-title":"Ann Surg Oncol."},{"key":"7751_CR11","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaoncol.2017.0774","volume":"3","author":"M Morrow","year":"2017","unstructured":"Morrow M, Abrahamse P, Hofer TP, Ward KC, Hamilton AS, Kurian AW, et al. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol. 2017;3:1352\u20137.","journal-title":"JAMA Oncol."},{"issue":"Suppl 3","key":"7751_CR12","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1245\/s10434-015-4829-0","volume":"22","author":"A Chung","year":"2015","unstructured":"Chung A, Gangi A, Amersi F, Bose S, Zhang X, Giuliano A. Impact of consensus guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on margins for breast-conserving surgery in stages 1 and 2 invasive breast cancer. Ann Surg Oncol. 2015;22(Suppl 3):S422\u20137.","journal-title":"Ann Surg Oncol."},{"key":"7751_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jamcollsurg.2018.01.050","volume":"227","author":"N Bhutiani","year":"2018","unstructured":"Bhutiani N, Mercer MK, Bachman KC, Heidrich SR, Martin RCG, II, Scoggins CR, et al. Evaluating the effect of margin consensus guideline publication on operative patterns and financial impact of breast cancer operation. J Am Coll Surg. 2018;227:6\u201311.","journal-title":"J Am Coll Surg."},{"key":"7751_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/jama.2012.43","volume":"307","author":"LE McCahill","year":"2012","unstructured":"McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, Engel JM, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307:467\u201375.","journal-title":"JAMA."},{"key":"7751_CR15","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/jama.2009.1450","volume":"302","author":"M Morrow","year":"2009","unstructured":"Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302:1551\u20136.","journal-title":"JAMA."},{"key":"7751_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/000313481007600319","volume":"76","author":"C Sanchez","year":"2010","unstructured":"Sanchez C, Brem RF, McSwain AP, Rapelyea JA, Torrente J, Teal CB. Factors associated with reexcision in patients with early-stage breast cancer treated with breast conservation therapy. Am Surg. 2010;76:331\u20134.","journal-title":"Am Surg."},{"key":"7751_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1001\/jamasurg.2014.926","volume":"149","author":"LG Wilke","year":"2014","unstructured":"Wilke LG, Czechura T, Wang C, Lapin B, Liederbach E, Winchester DP, Yao K. Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the National Cancer Data Base, 2004\u20132010. JAMA Surg. 2014;149:1296\u2013305.","journal-title":"JAMA Surg."},{"key":"7751_CR18","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/cncr.21071","volume":"103","author":"RJ Santiago","year":"2005","unstructured":"Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience. Cancer. 2005;103:2447\u201354.","journal-title":"Cancer."},{"key":"7751_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1245\/s10434-011-1907-9","volume":"19","author":"L Fortunato","year":"2012","unstructured":"Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, et al. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? Analysis of an institutional database over a 10-year period. Ann Surg Oncol. 2012;19:1107\u201314.","journal-title":"Ann Surg Oncol."},{"key":"7751_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1504473","volume":"373","author":"AB Chagpar","year":"2015","unstructured":"Chagpar AB, Killelea BK, Tsangaris TN, Butler M, Stavris K, Li F, et al. A randomized, controlled trial of cavity-shave margins in breast cancer. N Engl J Med. 2015;373:503\u201310.","journal-title":"N Engl J Med."},{"key":"7751_CR21","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1245\/s10434-018-6682-4","volume":"25","author":"RA Mukhtar","year":"2018","unstructured":"Mukhtar RA, Wong J, Piper M, Zhu Z, Fahrner-Scott K, Mamounas M, et al. Breast conservation and negative margins in invasive lobular carcinoma: the impact of oncoplastic surgery and shave margins in 358 patients. Ann Surg Oncol. 2018;25:3165\u201370.","journal-title":"Ann Surg Oncol."},{"key":"7751_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1001\/jamasurg.2015.5535","volume":"151","author":"AJ Isaacs","year":"2016","unstructured":"Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg. 2016;151:648\u201355.","journal-title":"JAMA Surg."},{"key":"7751_CR23","doi-asserted-by":"crossref","unstructured":"Truin W, Roumen RM, Siesling S, van der Heiden-van der Loo M, Duijm LE, Tjan-Heijnen VC, Voogd AC. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population-based study in the Netherlands. Ann Surg Oncol. 2015;22:1471\u20138.","DOI":"10.1245\/s10434-014-4175-7"},{"key":"7751_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ejso.2013.02.007","volume":"39","author":"N Biglia","year":"2013","unstructured":"Biglia N, Maggiorotto F, Liberale V, Bounous VE, Sgro LG, Pecchio S, et al. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol. 2013;39:455\u201360.","journal-title":"Eur J Surg Oncol."},{"key":"7751_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3816\/CBC.2010.n.007","volume":"10","author":"EJ Silberfein","year":"2010","unstructured":"Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, et al. Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer. 2010;10:52\u20138.","journal-title":"Clin Breast Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07751-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07751-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07751-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,17]],"date-time":"2021-01-17T13:40:21Z","timestamp":1610890821000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07751-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["7751"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07751-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Monica Morrow has received honoraria from Genomic Health and Roche. None of the remaining authors have conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}